Table 2 Jadad scales of reporting randomized controlled trials for meta-analysis.
Reference | Year | Randomization is mentioned | Appropriateness of randomization | Blinding is mentioned | Appropriateness of blinding | An account of all patients | Total |
|---|---|---|---|---|---|---|---|
CSI vs SW | |||||||
Eslamian et al. | 2016 | 1 | 1 | 1 | 0 | 1 | 4 |
Mardani-Kivi et al. | 2015 | 1 | 0 | 0 | 0 | 1 | 2 |
Porter et al. | 2005 | 1 | 1 | 0 | 0 | 1 | 3 |
Sorrentino et al. | 2008 | 1 | 1 | 0 | 0 | 0 | 2 |
Yucel et al. | 2010 | 1 | 0 | 0 | 0 | 1 | 2 |
CSI vs PT | |||||||
Celik et al. | 2016 | 1 | 1 | 1 | 0 | 1 | 4 |
Ryan et al. | 2014 | 1 | 1 | 0 | 0 | 1 | 3 |
CSI vs Insole | |||||||
Yucel et al. | 2013 | 1 | 1 | 0 | 0 | 1 | 3 |
CSI vs NSAIDs | |||||||
Biswas et al. | 2011 | 1 | 0 | 0 | 0 | 1 | 2 |
